Form 4 for SLDB Solid Biosciences Inc.
Accepted 2022-03-08 00:00:00 ET · period of report 2022-02-10 · accession 0001209191-22-017114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-03-08 | 2022-02-10 | SLDB | Ganot Ilan | CEO, Pres, Dir | S - Sale | $1.12 | -463 | 2,518 | -16% | -$518.56 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-10 | S | D | 463 | $1.12 | 2,518 | I Wife | — | — | (F1) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1). |